|
SLNCF Silence Therapeutics Plc 1479615 |
| Balance Sheet |
|
Current Assets
|
187,366,000 |
|
Assets
|
202,635,000 |
|
Current Liabilities
|
16,822,000 |
|
Liabilities
|
68,612,000 |
|
Equity
|
134,023,000 |
|
Shares Out
|
107,808,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-67,640,000 |
|
Investing Cash Flow
|
-21,966,000 |
| Market Analysis |
Market Cap
|
855,442,484 |
|
Price
|
1.47 |
|
BVPS
|
1.24 |
|
PB
|
1.18 |
|
EPS
|
-0.42 |
|
PS
|
0.01 |
|
FCF
|
-89,606,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLNCF documents filed with the SEC.
SLNCF Filings
Clear
